Epidermal growth factor receptor-Mutated Non-small-cell Lung Cancer with Intracranial Progressions and Stable Extracranial Diseases Benefit from Osimertinib Regardless of T790M Mutational Status.
- Resource Type
- Article
- Source
- Cancer Control: Journal of the Moffitt Cancer Center; 1/1/2022, Vol. 29, p1-9, 9p
- Subject
- Language
- ISSN
- 10732748